Innovative inhalation therapy for COPD patients

Mission

We are on a mission to improve the quality of life of COPD patients for which no adequate therapy is available by local administration of our proprietary lead compound.

Vision

We envision to run the majority of the drug development process in Groningen. Originating from the Groningen Research Institute of Pharmacy (GRIPH) we want to activate fellow researchers, companies and other stakeholders in the area of Groningen (‘in de omgeving
van, in de gouw, INGO’) to make project GRIPHINGO a success. Over 600.000 Dutch COPD patients expect no less.

About us

Martijn Zwinderman - CEO

Martijn R. H. Zwinderman is the co-founder, chief executive and
scientific officer of Griphingo Pharmaceuticals. He was born in Winschoten, The Netherlands, in 1990. He received his MSc degree in
Pharmacy at the University of Groningen in 2015 cum laude. He also completed the Bachelor’s Honours programme for excellent students and co-founded the university-wide student journal ‘Honours Review’. Since then, he has been a PhD student at the University of Groningen under the guidance of Professor Frank J.
Dekker. He authored on 11 scientific publications and is the first inventor of a dual warhead lead compound with anti-inflammatory and anti-fibrotic properties. He has obtained his PhD degree in April 2021.

Winant Zwinderman - CFO

Winant W. J. Zwinderman is the co-founder and
chief financial officer of Griphingo Pharmaceuticals. He was born in
Winschoten, The Netherlands, in 1993. He has a Masters in Accountancy and completed the postmaster study "Executive
Master of Accountancy" at the University of Groningen and the postmaster study "Executive Program of
Digital Auditing" at the University of Amsterdam.

Leave us a message

©